Article
Efficacy of antiviral therapy and host–virus interactions visualised using serial liver sampling with fine-needle aspirates
19 Jun 2023
Abstract excerpt
Background & Aims: Novel therapies for chronic hepatitis B (CHB), such as RNA interference, target all viral RNAs for degradation, whereas nucleoside analogues are thought to block reverse transcription with minimal impact on viral transcripts. However, limitations in technology and sampling frequency have been obstacles to measuring actual changes in HBV transcription in the liver of patients starting therapy....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
